3-Fluoro-4-hydroxyprolines: synthesis, conformational analysis, and stereoselective recognition by the VHL E3 ubiquitin ligase for targeted protein degradation

A Testa, X Lucas, GV Castro, KH Chan… - Journal of the …, 2018 - ACS Publications
Hydroxylation and fluorination of proline alters the pyrrolidine ring pucker and the trans: cis
amide bond ratio in a stereochemistry-dependent fashion, affecting molecular recognition of …

Structure-guided design and optimization of small molecules targeting the protein–protein interaction between the von Hippel–Lindau (VHL) E3 ubiquitin ligase and …

C Galdeano, MS Gadd, P Soares… - Journal of Medicinal …, 2014 - ACS Publications
E3 ubiquitin ligases are attractive targets in the ubiquitin–proteasome system, however, the
development of small-molecule ligands has been rewarded with limited success. The von …

Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel–Lindau (VHL) E3 Ubiquitin Ligase: Structure–Activity Relationships Leading to the Chemical Probe (2S,4R …

P Soares, MS Gadd, J Frost, C Galdeano… - Journal of medicinal …, 2018 - ACS Publications
The von Hippel–Lindau tumor suppressor protein is the substrate binding subunit of the VHL
E3 ubiquitin ligase, which targets hydroxylated α subunit of hypoxia inducible factors (HIFs) …

[HTML][HTML] Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation

C Maniaci, SJ Hughes, A Testa, W Chen… - Nature …, 2017 - nature.com
E3 ubiquitin ligases are key enzymes within the ubiquitin proteasome system which catalyze
the ubiquitination of proteins, targeting them for proteasomal degradation. E3 ligases are …

[HTML][HTML] Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders

CJ Diehl, A Ciulli - Chemical Society Reviews, 2022 - pubs.rsc.org
The von Hippel-Lindau (VHL) Cullin RING E3 ligase is an essential enzyme in the ubiquitin-
proteasome system that recruits substrates such as the hypoxia inducible factor for …

Targeted protein degradation and the enzymology of degraders

SL Fisher, AJ Phillips - Current opinion in chemical biology, 2018 - Elsevier
Targeted protein degradation is an emerging strategy for drug discovery that employs small
molecules to catalyze the ubiquitination of target proteins, ultimately causing their …

[HTML][HTML] Small Molecule Inhibitors of the Interaction Between the E3 Ligase VHL and HIF1α

DL Buckley, JL Gustafson, I Van Molle… - … (International Ed. in …, 2012 - ncbi.nlm.nih.gov
E3 ubiquitin ligases, such as the therapeutically relevant VHL, are challenging targets for
traditional medicinal chemistry, as their modulation requires targeting protein-protein …

Systematic potency and property assessment of VHL ligands and implications on PROTAC design

J Krieger, FJ Sorrell, AA Wegener, B Leuthner… - …, 2023 - Wiley Online Library
Herein, we describe a systematic SAR‐and SPR‐investigation of the peptidomimetic
hydroxy‐proline based VHL‐ligand VH032, from which most to‐date published VHL …

Chemical specification of E3 ubiquitin ligase engagement by cysteine-reactive chemistry

RC Sarott, I You, YD Li, ST Toenjes… - Journal of the …, 2023 - ACS Publications
Targeted protein degradation relies on small molecules that induce new protein–protein
interactions between targets and the cellular protein degradation machinery. Most of these …

[HTML][HTML] Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs

M Girardini, C Maniaci, SJ Hughes, A Testa… - Bioorganic & Medicinal …, 2019 - Elsevier
Abstract The von Hippel-Lindau (VHL) and cereblon (CRBN) proteins are substrate
recognition subunits of two ubiquitously expressed and biologically important Cullin RING …